BETHESDA, Md., Feb. 13, 2026 /PRNewswire/ -- Precision Biologics, Inc. CEO Philip M. Arlen, MD gives a Keynote presentation describing in vitro and in vivo efficacy of its novel tumor-specific ...
It is estimated that one-third of the 50 million people worldwide with epilepsy are resistant to anti-seizure medications. These patients, having drug-resistant epilepsy, have limited treatment ...
In today’s crowded, cost‑pressured pharma landscape, even proven brands struggle to stay on forecast. Missed patients, prescriber inertia, and fragmented execution mean opportunity is often not lost, ...
The ongoing Operation Sindoor, launched in the aftermath of Pakistan-sponsored terror in Pahalgam on April 22 that killed 26 people, is part of India’s response as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results